Metachronous Carcinomas of the Colon: Case Report

Kaplan, Louis; Shechter, Fred R.; Rasansky, Harry N.

doi:10.1016/s0016-5085(19)36288-2

Cited by 3 publications

(1 citation statement)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Metachronous cancer in an identical organ is defined as a second cancer occurring in the remnant tissue which does not exist at the time of resection of the first tumor, and can be observed, within the gastrointestinal organs, mostly in the colorectum and sometime in the stomach [6,7]. As an oversight might happen at the first diagnosis, some might advocate a minimum period to be necessary between the detection of the tumors [8].…”

Section: Discussionmentioning

confidence: 99%

Metachronous multiple adenocarcinomas of the pancreas

et al. 2011

View full text Add to dashboard Cite

We report a rare case of metachronous multiple adenocarcinoma of the pancreas. A 59-year-old Japanese man visited our institute for a routine workup as a hepatitis C virus carrier, resulting in detection of a 3-cm tumor in the pancreatic body by screening echogram. Results from several imaging modalities were consistent with pancreatic carcinoma. Distal pancreatectomy along with dissection of partial gastrectomy, transverse colectomy, and lymph node dissection were performed in November 2003. Histological examination confirmed a pancreatic ductal adenocarcinoma with a clear surgical margin and negative lymph node metastases. Gemcitabine was administered for 5 years, then suspended because no recurrent signs were found. The patient returned to our hospital in March 2009, with obstructive jaundice along with a 2-cm tumor in the head of the remnant pancreas. The condition of the patient was carefully investigated and extra-pancreatic metastatic lesions were not found; a pancreaticoduodenectomy was then carried out. Histological examination revealed a diagnosis of pancreatic adenocarcinoma arising from the remnant pancreas gland.

show abstract

Section: Discussionmentioning

confidence: 99%